Ataxia-Telangiectasia and Cellular Responses to DNA Damage

Cancer Research

Volumn 55, Issue 24, 1995, Pages 5991-6001

  Meyn, M Stephen ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HUMAN; LYMPHOCYTOPENIA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THYMUS ATROPHY;

APOPTOSIS; ATAXIA TELANGIECTASIA; CELL CYCLE; CHROMOSOME ABERRATIONS; DNA DAMAGE; DNA REPAIR; HUMAN; MODELS, THEORETICAL; MUTATION; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028880649     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (148)

1. Sedgwick, R. P., and Boder, E. Ataxia-telangiectasia. Handb. Clin. Neurol., 16: 347–423, 1991.
2. Swift, M., Reitnauer, P. J., Morrell, D., and Chase, C. L. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316: 1289–1294, 1987.
3. Cohen, M. M., and Levy, H. P. Chromosome instability syndromes. Adv. Hum. Genet., 18: 43–149, 1989.
4. Meyn, M. S. High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science (Washington DC), 260: 1327–1330, 1993.
5. Kobayashi, Y., Tycko, B., Soreng, A. L., and Sklar, J. Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J. Immunol., 147: 3201–3209, 1991.
6. Lipkowitz, S., Stern, M. H., and Kirsh, I. R. Hybrid T-cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J. Exp. Med., 172: 409–418, 1990.
7. Paterson, M. C., Smith, B. P., Lohman, P. H. M., Anderson, A. K., and Fishman, L. Defective excision repair of y-ray-damaged DNA in human ataxia-telangiectasia fibroblasts. Nature (Lond.), 260: 444–446, 1976.
8. Paterson, M. C., and Smith, P. J. Ataxia telangiectasia: an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu. Rev. Genet., 13: 291–318, 1979.
9. Singh, S. P., Mahamed, R., Salmond, C., and Lavin, M. F. Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells. Nucleic Acids Res., 16: 3919–3929, 1988.
10. Edwards, M. J., and Taylor, A. M. R. Unusual levels of ADP-ribose and DNA synthesis in ataxia telangiectasia cells following y-ray irradiation. Nature (Lond.), 287: 745–774, 1980.
11. Painter, R. B., and Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sei. USA, 77: 7315–7317, 1980.
12. McKinnon, P. J. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum. Genet., 75: 197–208, 1987.
13. Debenham, P. G., Webb, M. B., Stretch, A., and Thacker, J. Examination of vectors with two dominant, selectable genes for DNA repair and mutation studies in mammalian cells. Mutat. Res., 199: 145–158, 1988.
14. Cox, R., Masson, W. K., Debenham, P. G., and Webb, M. B. T. The use of recombinant DNA plasmids for the determination of DNA-repair and recombination in cultured mammalian cells. Br. J. Cancer, 46 (Suppl. VI): 67–72, 1984.
15. McFarlin, D. E., Strober, W., and Waldmann, T. A. Ataxia-telangiectasia. Medicine (Baltimore), 51: 281–314, 1972.
16. Carbonari, M., Cherchi, M., Paganelli, R., Giannini, G., Galli, E., Gaetano, C., Papetti, C., and Fiorilli, M. Relative increase of T cells expressing the 7/8 rather than the α/β receptor in ataxia-telangiectasia. N. Engl. J. Med., 322: 73–76, 1990.
17. Kojis, T. L., Gatti, R. A., and Sparkes, R. S. The cytogenetics of ataxia telangiectasia. Cancer Genet. Cytogenet., 56: 143–156, 1991.
18. Peterson, R. D. A., and Funkhouser, J. D. Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily. Immunol. Today, 10: 313–315, 1989.
19. Dasgupta, U. B., and Summers, W. C. Genetic recombination of herpes simplex virus, the role of the host cell and UV-irradiation of the virus. Mol. & Gen. Genet., 178: 617–623, 1980.
20. Timme, T. L., Wood, C. M., and Moses, R. E. Intermolecular plasmid recombination in fibroblasts from humans with DNA damage-processing defects. Plasmid, 22: 1–9, 1989.
21. Mirzayans, R., and Paterson, M. C. Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide. Carcinogenesis (Lond.), 12: 19–23, 1991.
22. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587–597, 1992.
23. Murray, A. W. Creative blocks: cell-cycle checkpoints and feedback controls. Nature (Lond.), 359: 599–604, 1992.
24. Masson, W. K., Weichselbaum, R. R., Nove, J., and Little, J. B. The repair of potentially lethal damage in X-irradiated cultures of normal and ataxia telangiectasia human fibroblasts. Int. J. Radiat. Biol., 39: 357–365, 1981.
25. Little, J. B., and Nagasawa, H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat. Res., 101: 81–93, 1985.
26. Arlett, C. F., and Priestley, A. Defective recovery from potentially lethal damage in some human fibroblast cell strains. Int. J. Radiat. Biol., 43: 157–167, 1983.
27. Fornace, A. J., Jr., Jackman, J., Hollander, M. C., Hoffman-Liebermann, B., and Liebermann, D. A. Genotoxic-stress-response genes and growth-arrest genes. GADD, MyD, and other genes induced by treatments eliciting growth arrest. Ann. NY Acad. Sci., 663: 139–153, 1992.
28. Kaini, B., Stein, B., Schönthal, A., Rahmsdorf, H. J., Ponta, H., and Herrlich, P. An uptake of the mammalian UV response: gene regulation and induction of a protective function. Life Sci., 182: 652–664, 1990.
29. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821–1828, 1994.
30. Battista, J. R., Donnelly, C. E., Ohta, T., and Walker, G. C. The SOS response and induced mutagenesis. Prog. Clin. Biol. Res., 340A: 169–178, 1990.
31. Weinen, T. A. Dual cell cycle checkpoints sensitive to chromosome replication and DNA damage in the budding yeast Saccharomyces cerevisiae. Radiat. Res., 132: 141–143, 1992.
32. al-Khodairy, F., and Carr, A. M. DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe. EMBO J., 11: 1343–1350, 1992.
33. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215–221, 1992.
34. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491–7495, 1992.
35. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 57:6304–6311, 1991.
36. el-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., and Wang, Y. WAF1/C1P1 is induced in p5i-mediated G, arrest and apoptosis. Cancer Res., 54: 1169–1174, 1994.
37. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G, arrest. Cell, 76: 1013–1023, 1994.
38. Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., and Hurwitz, J. cdk-interacting protein 1 directly binds with proliferating nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 8 holoenzyme. Proc. Natl. Acad. Sci. USA, 91: 8655–8659, 1994.
39. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574–578, 1994.
40. Komatsu, K., Okumura, Y., Kodama, S., Yoshida, M., and Miller, R. C. Lack of correlation between radiosensitivity and inhibition of DNA synthesis in hybrids A-T x HeLa. Int. J. Radiat. Biol., 56: 863–867, 1989.
41. Russell, K. J., Wiens, L. W., Demers, G. W., Galloway, D. A., Plön, S. E., and Groudine, M. Abrogation of the G2 checkpoint results in differential radiosensitization of the G, checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res., 55: 1639–1642, 1995.
42. Weinert, T. A., Kiser, G. L., and Hartwell, L. H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes & Dev., 8: 652–665, 1994.
43. Jimenez, G., Yucel, J., Rowley, R., and Subramani, S. The rad3* gene of Schizosaccharomyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc. Natl. Acad. Sci. USA, 89: 4952–4956, 1992.
44. Khanna, K. K., and Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene, 8: 3307–3312, 1993.
45. Canman, C. E., Wolff, A. C., Chen, C. Y., Fornace, A. J., Jr., and Kastan, M. B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res., 54: 5054–5058, 1994.
46. Zambetti-Bosseler, F., and Scott, D. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol., 39: 547–558, 1980.
47. Rudolph, N. S., and Latt, S. A. Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia. Mutat. Res., 211: 31–41, 1989.
48. Summers, W. C., Sarkar, S. N., and Glazer, P. M. Direct and inducible mutagenesis in mammalian cells. Cancer Surv., 4: 517–528, 1985.
49. Hilgers, G., Abrahams, P. J., Chen, Y. Q., Schouten, R., Cornelis, J. J., Lowe, J. E., van der Eb, A. J., and Rommelaere, J. Impaired recovery and mutagenic SOS-like responses in ataxia-telangiectasia cells. Mutagenesis, 4: 271–276, 1989.
50. Jeeves, W. P., and Rainbow, A. J. An aberration in γ-ray-enhanced reactivation of irradiated adenovirus in ataxia telangiectasia fibroblasts. Carcinogenesis (Lond.), 7: 381–387, 1986.
51. Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene, 10: 1053–1059, 1995.
52. Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J-M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., Bohr, V. A., Weeda, G., Hoeijmakers, J. H. J., Forrester, K., and Harris, C. C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet, 10: 188–195, 1995.
53. Smith, M. L., Chen, I. T., Zhan, Q., Bae, I., Chen, C. Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., and Fornace, A. J., Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (Washington DC), 266: 1376–1380, 1994.
54. Bennett, C. B., and Rainbow, A. J. Delayed expression of enhanced reactivation and decreased mutagenesis of UV-irradiated adenovirus in UV-irradiated ataxia telangiectasia fibroblasts. Mutagenesis, 3: 389–395, 1988.
55. Tomei, L. D., and Cope, F. O. (eds.). Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1991.
56. Kruman, I.I., Matylevich, N. P., Beletsky, I. P., Afanasyev, V. N., and Umansky, S. R. Apoptosis of murine BW 5147 thymoma cells induced by dexamethasone and y-irradiation. J. Cell. Physiol., 148: 267–273, 1991.
57. Yamada, T., and Ohyama, H. Radiation-induced interphase death of thymocytes is internally programmed apoptosis. Int. J. Radiat. Biol., 53: 65–75, 1988.
58. Boder, E., and Sedgwick, R. P. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics, 21: 526–554, 1958.
59. Amromin G. D., Boder, E., and Teplitz, R. Ataxia-telangiectasia with a 32 year survival. A clinicopathological report. J. Neuropathol. & Exp. Neurol., 38:621–643, 1979.
60. Agamanolis, D. P., and Greenstein, J. I. Ataxia-telangiectasia: report of a case with Lewy bodies and vascular abnormalities within cerebral tissue. J. Neuropathol. & Exp. Neurol., 39: 475–489, 1979.
61. Schimke, R. T., Kung, A. L., Rush, D. F., and Sherwood, S. W. Differences in mitotic control among mammalian cells. Cold Spring Harbor Symp. Quant. Biol., 56: 417–425, 1991.
62. Meyn, M. S., Strasfeld, L., and Allen, C. Testing the role of p53 in genetic instability and apoptosis in ataxia-telangiectasia. Int. J. Radiat. Biol., 66: 141–149, 1994.
63. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749–1753, 1995.
64. Greenwell, P. W., Kronmal, S. L., Porter, S. E., Gassenhuber, J., Obermaier, B., and Petes, T. D. TEL1, a gene involved in controlling telomere length in Saccharomyces cerevisiae, is homologous to the human ataxia telangiectasia (ATM) gene. Cell, 82: 823–830, 1995.
65. Hari, K. L., Santerre, A., Sekelsky, J. J., McKim, K. S., Boyd, J. B., and Hawley, R. S. The mei-41 gene of Drosophila melanogaster is a structural and functional homology of the human ataxia telangiectasia gene. Cell, 82: 815–822, 1995.
66. Phipps, J., Nasim, A., and Miller, D. R. Recovery, repair, and mutagenesis in Schizosaccharomyces pombe. Adv. Genet., 23: 1–72, 1985.
67. Harriman, W., Volk, H., Defranoux, N., and Wabl, M. Immunoglobulin class switch recombination. Annu. Rev. Immunol., 11: 361–384, 1993.
68. Strominger, M. L. Developmental biology of T-cell receptors. Science (Washington DC), 244: 943–950, 1989.
69. Robey, E., and Fowlkes, B. J. Selective events in T-cell development. Annu. Rev. Immunol., 12: 675–705, 1994.
70. Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E., Salter, D. M., Bird, C. C., Wyllie, A. H., and Hooper, M. L. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9: 603–609, 1994.
71. Bischoff, F. Z., Yim, S. O., Pathak, S., Grant, G., Siciliano, M. J., Giovanella, B. C., Strong, L. C., and Tainsky, M. A. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res., 50: 7979–7984, 1990.
72. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923–935, 1992.
73. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937–948, 1992.
74. Hecht, F., Koler, R. D., Rigas, D. A., Dahnke, G. S., Case, M. P., Tisdale, V., and Miller, R. W. Leukaemia and lymphocytes in ataxia-telangiectasia. Lancet, 2: 1193, 1966.
75. Rosin, M. P., Ochs, H. D., Gatti R. A., and Boder, E. Heterogeneity of chromosomal breakage levels in epithelial tissue of ataxia-telangiectasia homozygotes and heterozygotes. Hum. Genet., 83: 133–138, 1989.
76. Aguilar, M. J., Kamoshita, S., Landing, B. H., Boder, E., and Sedgwick, R. P. Pathological observations in ataxia-telangiectasia. A report on 5 cases. J. Neuropathol. & Exp. Neurol., 27: 659–676, 1968.
77. Bigbee, W. L., Langlois, R. G., Swift, M., and Jensen, R. H. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia-telangiectasia. Am. J. Hum. Genet., 44: 402–408, 1989.
78. Weinert, T. A., and Hartwell, L. H. Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage. Mol. Cell. Biol., 10: 6554–6564, 1990.
79. Pandita, T. K., Pathak, S., and Geard, C. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. Cell Genet., 71: 86–93, 1995.
80. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921–1929, 1992.
81. Hartwell, L. H. Twentγ-five years of cell cycle genetics. Genetics, 129: 975–980, 1991.
82. Cornforth, M. N., and Bedford, J. S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science (Washington DC), 227: 1589–1591, 1985.
83. Nagasawa, H., Latt, S. A., Lalande, M. E., and Little, J. B. Effects of X-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia AT fibroblasts. Mutat. Res., 148: 71–82, 1985.
84. Carbone, D. P., and Minna, J. D. Antioncogenes and human cancer. Annu. Rev. Med., 44:451–464, 1993.
85. Hecht, F., and Hecht, B. K. Cancer in ataxia-telangiectasia patients. Cancer Genet. Cytogenet., 46: 9–19, 1990.
86. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847–849, 1993.
87. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849–852, 1993.
88. Blocher, D., Sigut, D., and Hannan, M. A. Fibroblasts from ataxia telangiectasia AT and AT heterozygotes show an enhanced level of residual double-strand breaks after low dose-rate γ-irradiation as assayed by pulsed field gel electrophoresis. Int. J. Radiat. Biol., 60: 791–802, 1991.
89. Zerbini, C., Weinberg, D. S., Hollister, K. A., and Perez-Atayde, A. R. DNA ploidy abnormalities in the liver of children with hereditary tyrosinemia type I. Correlation with histopathologic features. Am. J. Pathol., 140: 1111–1119, 1992.
90. Allan, D. J. Radiation-induced apoptosis: its role in a MADCaT mitosis-apoptosis-differentiation-calcium toxicity scheme of cytotoxicity mechanisms. Int. J. Radiat. Biol., 62: 145–152, 1992.
91. Taylor, A. M. R., Harnden, D. G., Arlett, C. F., Harcourt, S. A., Lehmann, A. R., Stevens, S., and Bridges, B. A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature (Lond.), 258: 427–428, 1975.
92. Lehman, A. R., and Stevens, S. The production and repair of double strand breaks in cells from normal humans and from patients with ataxia telangiectasia. Biochim. Biophys. Acta, 474: 49–60, 1977.
93. Eady, J. J., Peacock, J. H., and McMillan, T. J. Host cell reactivation of γ-irradiated adenovirus 5 in human cell lines of varying radiosensitivity. Br. J. Cancer, 66: 113–118, 1992.
94. Sikpi, M. O., Freedman, M. L., Dry, S. M., and Lurie, A. G. Mutation spectrum in γ-irradiated shuttle vector replicated in ataxia-telangiectasia lymphoblasts. Radiat. Res., 130: 331–339, 1992.
95. Muriel, W. J., Lamb, J. R., and Lehmann, A. R. UV mutation spectra in cell lines from patients with Cockayne's syndrome and ataxia telangiectasia, using the shuttle vector pZ189. Mutat. Res., 254: 119–123, 1991.
96. Pandita, T. K., and Hittelman, W. N. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat. Res., 131: 214–223, 1992.
97. Taylor, A. M. R. Unrepaired DNA strand breaks in irradiated ataxia-telangiectasia lymphocytes suggested from cytogenetic observations. Mutat. Res., 50: 407–418, 1978.
98. Taylor, A. M. R., Metcalfe, J. A., and McConville, C. Increased radiosensitivity and the basic defect in ataxia telangiectasia. Int. J. Radiat. Biol., 56: 677–684, 1989.
99. Smith, P. J., and Paterson, M. C. Effect of aphidicolin on de novo DNA synthesis, DNA repair and cytotoxicity in γ-irradiated human fibroblasts. Implications for the enhanced radiosensitivity in ataxia telangiectasia. Biochim. Biophys. Acta, 739: 17–26, 1983.
100. Kapp, L. N., Painter, R. B., Yu, L-C., van Loon, N., Richard, C. W., III, James, M. R., Cox, D. R., and Murnane, J. P. Cloning of a candidate gene for ataxia-telangiectasia group D. Am. J. Hum. Genet., 51: 45–54, 1992.
101. Green, M. H., Lowe, J. E., Arlett, C. F., Harcourt, S. A., Burke, J. F., James, M. R., Lehmann, A. R., and Povey, S. M. A γ-raγ-resistant derivative of an ataxia telangiectasia cell line obtained following DNA-mediated gene transfer. J. Cell Sci. Suppl., 6: 127–137, 1987.
102. Kunz, B. A., and Haynes, R. H. Phenomenology and genetic control of mitotic recombination in yeast. Annu. Rev. Genet., 15: 57–89, 1981.
103. Hahn, G. M., and Little, J. B. Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. Curr. Topics Radiat. Res. Q., 8: 39–83, 1972.
104. Weinert, T. A., and Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science (Washington DC), 241: 317–322, 1988.
105. Rowley, R., Subramani, S., and Young, P. G. Checkpoint controls in Schizosaccharomyces pombe: radl. EMBO J., 11: 1335–1342, 1992.
106. Iliakis, G. The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. Bioessays, 13: 641–648, 1991.
107. Elkind, M. M. DNA damage and cell killing: cause and effect? Cancer (Phila.), 56: 2351–2363, 1985.
108. Natarajan, A. T., and Obe, G. Molecular mechanisms involved in the production of chromosomal aberrations III: restriction endonucleases. Chromosoma (Berl.), 90: 120–127, 1984.
109. Bender, M. A., Griggs, H. G., and Bedford, J. S. Mechanisms of chromosomal aberration production. III. Chemicals and ionizing radiations. Mutat. Res., 23: 197–212, 1974.
110. Bedford, J. S., Mitchell, J. B., Griggs, H. G., and Bender, M. A. Radiation-induced cellular reproductive death and chromosome aberrations. Radiat. Res., 76: 573–586, 1978.
111. Carrano, A. V. Chromosome aberrations and radiation-induced cell death. II. Predicted and observed cell survival. Mutat. Res., 17: 355–366, 1973.
112. Hopwood, L. E., and Tolmach, L. J. Manifestations of damage from ionizing radiation in mammalian cells in the postirradiation generations. Adv. Radiat. Biol., 8: 317–362, 1978.
113. Beamish, H., and Lavin, M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol., 65: 175–184, 1994.
114. Imray, F. P., and Kidson, C. Perturbations of cell-cycle progression in γ-irradiated ataxia telangiectasia and Huntington's disease cells detected by DNA flow cytometric analysis. Mutat. Res., 112: 369–382, 1983.
115. Seyschab, H., Chindler, D., Friedl, R., Barbi, G., Oltshauser, E., Fryns, J. P., Hanefeld, F., Korinthenberg, R., and Krä;geloh-Mann, I. Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes. Eur. J. Pediatr., 151: 756–760, 1992.
116. Foledano, S. R., and Lange, B. J. Ataxia-telangiectasia and acute lymphoblastic leukemia. Cancer (Phila.), 45: 1675–1678, 1980.
117. Eyre, J. A., Gardner-Medwin, D., and Summerfield, G. P. Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia. Arch. Dis. Child., 63: 1079–1093, 1988.
118. Kojis, T. L., Schreck, R. R., Gatti, R. A., and Sparkes, R. S. Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia. Hum. Genet., 83: 347–352, 1989.
119. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815–1823, 1994.
120. Shiloh, Y., Tabor, E., and Becker, Y. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis (Lond.), 4: 1317–1322, 1982.
121. Burger, R. M., Drlica, K., and Birdsall, B. The DNA cleavage of iron bleomycin. J. Biol. Chem., 269: 25978–25985, 1994.
122. Anderson, C. W. DNA damage and the DNA-activated protein kinase. Trends Biochem. Sci., 78: 433–437, 1993.
123. Gottlieb, T. M., and Jackson, S. P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell, 72: 131–142, 1993.
124. Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., and Brown, J. M. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science (Washington DC), 267: 1178–1183, 1995.
125. Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., and Jackson, S. P. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine seid mutation. Cell, 80: 813–823, 1995.
126. Van Buul, P. P., De Rooij, D. G., Zandman, I. M., Grigorova, M., and Van Duyn-Goedhart, A. X-raγ-induced chromosomal aberrations and cell killing in somatic and germ cells of the seid mouse. Int. J. Radiat. Biol., 67: 549–555, 1995.
127. Troelstra, C., and Jaspers, N. G. Recombination and repair. Ku starts at the end. Curr. Biol., 4: 1149–1151, 1994.
128. Taccioli, G. E., Gottlieb, T. M., Blunt, T., Priestley, A., Demengeot, J., Mizuta, R., Lehmann, A. R., Alt, F. W., Jackson, S. P., and Jeggo, P. A. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science (Washington DC), 265: 1442–1445, 1994.
129. Lees-Miller, S. P., Godbout, R., Chan, D. W., Weinfeld, M., Day, R. S., III, Barron, G. M., and Allalunis-Turner, J. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (Washington DC), 267: 1183–1186, 1995.
130. Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82: 849–856, 1995.
131. Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R., and Hall, M. N. TORI and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell, 5: 105–118, 1994.
132. Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., and Hall, M. H. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G, progression. Cell, 73: 585–596, 1993.
133. Kapeller, R., and Cantley, L. C. Phosphatidylinositol 3-kinase. Bioessays, 16: 565–576, 1994.
134. Dhand, R., Hiles, I., Panayotou, G., Roche, S., Fry, M. J., Gout, I., Totty, N. F., Truong, O., Vicendo, P., Yonezawa, K., Kasuga, M., Courtneidge, S. A., and Waterfiel, M. D. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J., 13: 522–533, 1994.
135. Stack, J. H., and Emr, S. D. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. J. Biol. Chem., 269: 31552–31562, 1994.
136. Lane, D. P. Cancer: p53, guardian of the genome. Nature (Lond.), 358: 15–16, 1992.
137. Yao, R., and Cooper, G. M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science (Washington DC), 267: 2003–2006, 1995.
138. Knox, K. A., and Gordon, J. Protein tyrosine kinases couple the surface immunoglobulin of germinal center B cells to phosphatidylinositol-dependent and -independent pathways of rescue from apoptosis. Cell Immunol., 155: 62–76, 1994.
139. Dive, C., Evans, C. A., and Whetton, A. D. Induction of apoptosis: new targets for cancer chemotherapy. Semin. Cancer Biol., 3: 417–427, 1992.
140. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51: 3075–3079, 1991.
141. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543–546, 1992.
142. Keldysh, P. L., Dragani, T. A., Fleischman, E. W., Konstantinova, L. N., Perevoschikov, A. G., Pierotti, M. A., Delia Porta, G., and Kopnin, B. P. llq deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes & Cancer, 6: 45–50, 1993.
143. Carter, S. L., Negrini, M., Baffa, R., Gillum, D. R., Rosenberg, A. L., Schwartz, G. F., and Croce, C. M. Loss of heterozygosity at 1 lq22-q23 in breast cancer. Cancer Res., 54: 6270–6274, 1994.
144. Pejovic, T. Genetic changes in ovarian cancer. Ann. Med., 27: 73–78, 1995.
145. Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewer, C., Liao, S., Busbγ-Earle, R. M., Williams, A. W., Steel, C. M., Bird, C. C., Stanbridge, E. J., and Evans, G. A. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc. Natl. Acad. Sci. USA, 91: 6953–6957, 1994.
146. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Molec. Genet., 4: 2025–2032, 1995.
147. Kato, R., and Ogawa, H. An essential gene, ESR1, is required for mitotic cell growth, DNA repair, and meiotic recombination in Saccharomyces cerevisiae. Nuclear Acids Res., 22:3104–3112, 1994.
148. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 215: 403–410, 1990.